Logo image of WOK

WORK MEDICAL TECHNOLOGY GR-A (WOK) Stock Fundamental Analysis

NASDAQ:WOK - Nasdaq - KYG9767H1092 - Common Stock - Currency: USD

0.897  +0.03 (+3.1%)

Premarket: 0.8701 -0.03 (-3%)

Fundamental Rating

1

Taking everything into account, WOK scores 1 out of 10 in our fundamental rating. WOK was compared to 188 industry peers in the Health Care Equipment & Supplies industry. WOK may be in some trouble as it scores bad on both profitability and health. WOK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year WOK was profitable.
WOK had a negative operating cash flow in the past year.
WOK Yearly Net Income VS EBIT VS OCF VS FCFWOK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.31%, WOK is in the better half of the industry, outperforming 73.40% of the companies in the same industry.
WOK has a Return On Equity of 0.85%. This is in the better half of the industry: WOK outperforms 73.40% of its industry peers.
WOK has a better Return On Invested Capital (1.11%) than 68.09% of its industry peers.
Industry RankSector Rank
ROA 0.31%
ROE 0.85%
ROIC 1.11%
ROA(3y)-1.96%
ROA(5y)N/A
ROE(3y)-5.57%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WOK Yearly ROA, ROE, ROICWOK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

WOK's Profit Margin of 0.83% is fine compared to the rest of the industry. WOK outperforms 73.94% of its industry peers.
WOK's Operating Margin of 3.04% is fine compared to the rest of the industry. WOK outperforms 68.09% of its industry peers.
Looking at the Gross Margin, with a value of 30.54%, WOK is doing worse than 75.53% of the companies in the same industry.
WOK's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.04%
PM (TTM) 0.83%
GM 30.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.79%
GM growth 5YN/A
WOK Yearly Profit, Operating, Gross MarginsWOK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 -20

More info and screens

1

2. Health

2.1 Basic Checks

WOK has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
WOK has more shares outstanding than it did 1 year ago.
The debt/assets ratio for WOK is higher compared to a year ago.
WOK Yearly Shares OutstandingWOK Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M
WOK Yearly Total Debt VS Total AssetsWOK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of 1.28, we must say that WOK is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.28, WOK is in line with its industry, outperforming 53.19% of the companies in the same industry.
A Debt/Equity ratio of 1.01 is on the high side and indicates that WOK has dependencies on debt financing.
WOK has a worse Debt to Equity ratio (1.01) than 77.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF N/A
Altman-Z 1.28
ROIC/WACC0.17
WACC6.4%
WOK Yearly LT Debt VS Equity VS FCFWOK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M -5M 10M -10M

2.3 Liquidity

A Current Ratio of 1.03 indicates that WOK should not have too much problems paying its short term obligations.
WOK's Current ratio of 1.03 is on the low side compared to the rest of the industry. WOK is outperformed by 88.83% of its industry peers.
WOK has a Quick Ratio of 1.03. This is a bad value and indicates that WOK is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.87, WOK is doing worse than 82.45% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 0.87
WOK Yearly Current Assets VS Current LiabilitesWOK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

0

3. Growth

3.1 Past

WOK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -3670.13%.
Looking at the last year, WOK shows a very negative growth in Revenue. The Revenue has decreased by -15.18% in the last year.
The Revenue for WOK have been decreasing by -36.93% on average. This is quite bad
EPS 1Y (TTM)-3670.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-352.96%
Revenue 1Y (TTM)-15.18%
Revenue growth 3Y-36.93%
Revenue growth 5YN/A
Sales Q2Q%-63.96%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
WOK Yearly Revenue VS EstimatesWOK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

WOK is valuated quite expensively with a Price/Earnings ratio of 89.70.
Based on the Price/Earnings ratio, WOK is valued a bit cheaper than 65.43% of the companies in the same industry.
WOK's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.25.
Industry RankSector Rank
PE 89.7
Fwd PE N/A
WOK Price Earnings VS Forward Price EarningsWOK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of WOK indicates a rather cheap valuation: WOK is cheaper than 94.15% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.5
WOK Per share dataWOK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

WOK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WORK MEDICAL TECHNOLOGY GR-A

NASDAQ:WOK (5/30/2025, 8:00:02 PM)

Premarket: 0.8701 -0.03 (-3%)

0.897

+0.03 (+3.1%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.83%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap22.06M
AnalystsN/A
Price TargetN/A
Short Float %3.61%
Short Ratio1.38
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 89.7
Fwd PE N/A
P/S 1.63
P/FCF N/A
P/OCF N/A
P/B 1.67
P/tB 1.82
EV/EBITDA 8.5
EPS(TTM)0.01
EY1.11%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0.55
BVpS0.54
TBVpS0.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.31%
ROE 0.85%
ROCE 2.57%
ROIC 1.11%
ROICexc 1.43%
ROICexgc 1.49%
OM 3.04%
PM (TTM) 0.83%
GM 30.54%
FCFM N/A
ROA(3y)-1.96%
ROA(5y)N/A
ROE(3y)-5.57%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.79%
GM growth 5YN/A
F-Score3
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF N/A
Debt/EBITDA 7.31
Cap/Depr 656.39%
Cap/Sales 68.25%
Interest Coverage 0.76
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.03
Quick Ratio 0.87
Altman-Z 1.28
F-Score3
WACC6.4%
ROIC/WACC0.17
Cap/Depr(3y)251.52%
Cap/Depr(5y)N/A
Cap/Sales(3y)31.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3670.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-352.96%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.18%
Revenue growth 3Y-36.93%
Revenue growth 5YN/A
Sales Q2Q%-63.96%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1081.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-806.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-200.83%
OCF growth 3YN/A
OCF growth 5YN/A